Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 22, 2019
Pharmacy Choice - News - Over-the-Counter Drugs - January 22, 2019

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 231     Next >>     Go To Page:

12/22/18 - Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
-Cosmos Holdings, Inc., an international pharmaceutical company, announced the closing of its acquisition of Cosmofarm Ltd, a privately held company located in Athens, Greece. We are excited to announce the closing of this acquisition and to have Cosmofarms talented team become part of Cosmos Holdings, Cosmos Holdings CEO Gregory Siokas commented.
12/21/18 - ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Entry into a Material Definitive Agreement
ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 Entry into a Material Definitive Agreement. On December 20, 2018 we received a $200,000 loan from John Schutte, which combined with earlier loans, total $4.35 million in loans from Mr. Schutte. In connection with the $200,000 loan, we issued a
12/21/18 - Alexion Receives Early FDA Approval for ULTOMIRIS? (Ravulizumab-cwvz) in Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has approved ULTOMIRIS?, the first and only long-acting C5 complement inhibitor administered every eight weeks, for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria, a debilitating ultra-rare blood disorder characterized by...
12/21/18 - Chairman Alexander: This Congress, HELP Committee Produced 18 Laws Including 'Landmark' Opioid Legislation to Combat Nation's Most Pressing Public Health Crisis
Lamar Alexander, R- Tennessee, chairman of the Senate Health, Education, Labor and Pensions Committee, issued the following news release:. And last August, the president signed into law the FDA user fee agreements that will help bring new drugs and devices to patients more quickly. Alexander concluded: "While we have accomplished quite a bit workin
12/21/18 - Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
Cosmos Holdings, Inc., an international pharmaceutical company, announced the closing of its acquisition of Cosmofarm Ltd, a privately held company located in Athens, Greece.. About Cosmos Holdings, Inc. Cosmos Holdings Inc. is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and in Harlow, UK. The Company has a tra
12/21/18 - Dietary Supplements: Dubious Value, Hidden Dangers [Asharq Alawsat (Saudi Arabia)]
Pieter Cohen, an associate professor of medicine at Harvard Medical School who studies dietary supplements. The Dietary Supplement Health and Education Act of 1994 defined supplements as foods, not drugs. "Supplements can be sold and advertised as improving health without any evidence that they actually work in humans," says Dr. Cohen.
12/21/18 - Drug-Maker, GSK, To Split After Striking Pfizer Consumer Health Deal
GlaxoSmithKline plans to split into two businesses- one for prescription drugs and vaccines, the other for over-the-counter products- after forming a new joint venture with Pfizer's consumer health division. On Wednesday, however, she announced that GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 b
12/21/18 - FDA identifies pathways for hemp ingredients in foods and supplements
Gottlieb s statement noted that the Farm Bill preserves FDA s current authority to regulate products containing cannabis or cannabis-derived compounds, and declared that such ingredients clearly including hemp and hemp derivatives, such as cannabidiol are treated as we do any other FDA- regulated products. The Commissioner also re
12/21/18 - Global Dermatological Products Market Augmented Expansion to be Registered by 2028 [ClickPress (UK)]
Biologic agents or protein-based drugs are increasingly used in dermatology for treatment of psoriasis. These products have also gained traction in the treatment of other inflammatory skin diseases. Based on the regulatory approach of biosimilars, increasing number of biosimilar drugs are set to enter Europe and the US in the coming years.
12/21/18 - Nuvo Pharmaceuticals (Ireland) DAC Enters into Resultz License and Supply Agreement with Heumann Pharma GmbH & Co. Generica KG for Germany
-Nuvo Pharmaceuticals Inc., a globally focused, healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that its wholly owned subsidiary, Nuvo Pharmaceuticals DAC has entered into a license and supply agreement with Heumann Pharma GmbH& Co. Generica KG for the exclusive right to...
12/21/18 - Nuvo Pharmaceuticals? (Ireland) DAC Enters into Resultz License and Supply Agreement with Heumann Pharma GmbH & Co. Generica KG for Germany
-Nuvo Pharmaceuticals Inc., a globally focused, healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that its wholly owned subsidiary, Nuvo Pharmaceuticals DAC has entered into a license and supply agreement with Heumann Pharma GmbH& Co. Generica KG for the exclusive right to...
12/21/18 - RECORDATI ACQUIRES TONIPHARM S.A.S. IN FRANCE
Milan, 21 December 2018 Recordati announces the signing of an agreement for the acquisition of 100% of the share capital of Tonipharm S.A.S., a French company based in Boulogne-Billancourt near Paris, active mainly in the self-medication market with over-the-counter products. Recordati, established in 1926, is an international pharmaceutical gro
12/21/18 - UPDATE Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
Cosmos Holdings, Inc., an international pharmaceutical company, announced the closing of its acquisition of Cosmofarm Ltd, a privately held company located in Athens, Greece.. About Cosmos Holdings, Inc. Cosmos Holdings Inc. is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and in Harlow, UK. The Company has a tra
12/20/18 - ASAM Submits Comments to FDA Regarding Strategies to Increase Naloxone Availability
The American Society of Addiction Medicine issued the following news release:. On December 14, ASAM submitted comments to the Food and Drug Administration in response to a request for comment ahead of a public advisory committee meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory
12/20/18 - GlaxoSmithKline, Pfizer to merge consumer healthcare units [New Indian Express (India)]
LONDON: Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines. The tie-up of over-the-counter brands including GSK's Sensodyne toothpaste with Pfizer' s Centrum multivitamins paves the way for British group GSK to have two UK- listed companies, one
12/20/18 - Janssen Submits Application To U.S. FDA Seeking Approval Of STELARA (ustekinumab) For Treatment Of Moderately To Severely Active Ulcerative Colitis
The Janssen Pharmaceutical Companies of Johnson& Johnson announced today the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration seeking approval of STELARA for the treatment of adults with moderately to severely active ulcerative colitis. "We're excited to bring this innovative therapy, with a
12/20/18 - Kirkland Represents Bristol-Myers Squibb on Offer From Taisho Pharmaceutical Holdings to Purchase UPSA Consumer Health Business for $1.6 Billion
Kirkland& Ellis LLP advised Bristol-Myers Squibb Company, a global biopharmaceutical company, on its offer from Taisho Pharmaceutical Holdings Co., Ltd. to purchase Bristol-Myers Squibb's UPSA consumer health business for $1.6 billion. Taisho Pharmaceutical Holdings Co., Ltd is the largest over-the-counter drug company in Japan, with over a century
12/20/18 - Pain Management Market Professional Survey, Regional Analysis, Growth Factors, Demand, Recent Trends and Forecast to 2023 by MRFR
The Americas dominates the Pain Management Market owing to the increasing prevalence of chronic pain, well-developed technology, high healthcare expenditure, and the presence of leading players. According to a study published in the Drug and Alcohol Dependence Journal in 2017, more than 100 million adult Americans are living with chronic pain.
12/20/18 - Sen. Lamar Alexander (R-TN) News Release
U.S. Senate Health, Education, Labor and Pensions Committee Chairman Lamar Alexander today said, "over the last two years, this committee has produced solutions that will have an impact on the lives of virtually every American." And last August, the president signed into law the FDA user fee agreements that will help bring new drugs and devices to
12/20/18 - Solutions for American families include improved career and technical education programs; Collins "gag rule bill to help patients pay less for medication, and new law to speed safe new drugs and devices to patients
U.S. Senate Health, Education, Labor and Pensions Committee Chairman Lamar Alexander today said, "over the last two years, this committee has produced solutions that will have an impact on the lives of virtually every American." And last August, the president signed into law the FDA user fee agreements that will help bring new drugs and devices to
12/20/18 - Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange
Our dual listing on the NYSE and TSE reflects our position as a leading global biopharmaceutical company and will provide wider capital markets access with expanded trading hours for our investors worldwide, said Costa Saroukos, Chief Financial Officer of Takeda. We look forward to closing our acquisition of Shire in the coming weeks and d
12/19/18 - OTC Vitamin and Dietary Supplement Sales Growing at over 6% Annually: OTC Vitamins & Dietary Supplements Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022
New York, NY 12/19/2018 Over-the-counter vitamins and dietary supplements are sold directly to consumers without any medical prescription. In many countries, OTC vitamins and dietary supplement products are regulated to ensure that they are effective and safe when used. A notable growth in demand for OTC vitamins and dietary supplements has b
12/19/18 - Taisho Offers To Purchase Bristol-Myers Squibb's UPSA Consumer Health Unit
NEW YORK CITY- Bristol-Myers Squibb Company announced that Taisho Pharma, an over-the-counter drug company in Japan, has offered to purchase Bristol-Myers Squibb's UPSA consumer health business for $1.6 billion. UPSA is a French pharmaceutical company and brand owned by Bristol-Myers Squibb. With Taisho we have found an experienced and reliable buy
12/19/18 - Taisho Pharmaceutical to buy Bristol-Myers' OTC unit for $1.6 bil.
Taisho Pharmaceutical Holdings Co. will purchase Bristol-Myers Squibb Co.' s over-the-counter drug unit in France for $1.6 billion to gain a footing in the European consumer drug market, the companies said Wednesday. Taisho's expansion into the European market will follow its entry into the OTC drug market in Southeast Asia with the purchase of...
12/19/18 - Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange
'Our dual listing on the NYSE and TSE reflects our position as a leading global biopharmaceutical company and will provide wider capital markets access with expanded trading hours for our investors worldwide,' said Costa Saroukos, Chief Financial Officer of Takeda.' We look forward to closing our acquisition of Shire in the coming weeks and driving
Articles(s): 1 - 25 of 231     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415